pimorimos 1%用于儿童积极治疗atp皮炎的理由

Current Paediatrics Pub Date : 2021-11-07 DOI:10.15690/VSP.V20I5.2310

Н. Н. Мурашкин, Роман Алексеевич Иванов, Э. Т. Амбарчян, Р. В. Епишев, А. И. Материкин, Л. А. Опрятин, А. А. Савелова

{"title":"pimorimos 1%用于儿童积极治疗atp皮炎的理由","authors":"Н. Н. Мурашкин, Роман Алексеевич Иванов, Э. Т. Амбарчян, Р. В. Епишев, А. И. Материкин, Л. А. Опрятин, А. А. Савелова","doi":"10.15690/VSP.V20I5.2310","DOIUrl":null,"url":null,"abstract":"Atopic dermatitis (AtD) is multifactorial inflammatory skin disease with high prevalence in pediatric population. It is crucial to implement long-term maintenance therapy to prevent AtD exacerbations according to current clinical guidelines and expert reports. The article summarizes the results of the major studies on using pimecrolimus 1% cream. Its efficacy and safety in long-term proactive therapy of children with AtD are presented.","PeriodicalId":10919,"journal":{"name":"Current Paediatrics","volume":"107 1","pages":"376-382"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Обоснование применения крема пимекролимус 1% для проактивной терапии атопического дерматита у детей\",\"authors\":\"Н. Н. Мурашкин, Роман Алексеевич Иванов, Э. Т. Амбарчян, Р. В. Епишев, А. И. Материкин, Л. А. Опрятин, А. А. Савелова\",\"doi\":\"10.15690/VSP.V20I5.2310\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Atopic dermatitis (AtD) is multifactorial inflammatory skin disease with high prevalence in pediatric population. It is crucial to implement long-term maintenance therapy to prevent AtD exacerbations according to current clinical guidelines and expert reports. The article summarizes the results of the major studies on using pimecrolimus 1% cream. Its efficacy and safety in long-term proactive therapy of children with AtD are presented.\",\"PeriodicalId\":10919,\"journal\":{\"name\":\"Current Paediatrics\",\"volume\":\"107 1\",\"pages\":\"376-382\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-11-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Paediatrics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15690/VSP.V20I5.2310\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Paediatrics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15690/VSP.V20I5.2310","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

摘要

特应性皮炎(AtD)是一种多因素炎症性皮肤病，在儿科人群中发病率较高。根据目前的临床指南和专家报告，实施长期维持治疗以预防AtD恶化至关重要。本文综述了1%吡美莫司乳膏应用的主要研究结果。对其在儿童AtD长期积极治疗中的有效性和安全性进行了评价。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Обоснование применения крема пимекролимус 1% для проактивной терапии атопического дерматита у детей

Atopic dermatitis (AtD) is multifactorial inflammatory skin disease with high prevalence in pediatric population. It is crucial to implement long-term maintenance therapy to prevent AtD exacerbations according to current clinical guidelines and expert reports. The article summarizes the results of the major studies on using pimecrolimus 1% cream. Its efficacy and safety in long-term proactive therapy of children with AtD are presented.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Current Paediatrics

自引率

0.00%

发文量